Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Overweight or Obese, Type 2 Diabetes”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT07564414
What this trial is testing

A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight

Who this might be right for
ObesityType 2 Diabetes
Novo Nordisk A/S 2,500
Not applicableStudy completedNCT07417618
What this trial is testing

INcreTin-based thERapies for Cardiovascular Event PrevenTion in Patients With and Without ASCVD (INTERCEPT-ASCVD)

Who this might be right for
Type 2 DiabetesOverweightASCVD
Brigham and Women's Hospital 60,000
Large-scale testing (Phase 3)UnknownNCT02235519
What this trial is testing

Pleiotropic Effects of Azilsartan Medoxomil Over Insulin Resistance in Obese, Diabetic and Hypertensive Patients

Who this might be right for
HypertensionObesityType 2 Diabetes Mellitus
Hospital General de México Dr. Eduardo Liceaga 300
Testing effectiveness (Phase 2)Looking for participantsNCT06924320
What this trial is testing

MET233 in Combination With MET097 in Individuals With Obesity or Overweight With or Without Diabetes

Who this might be right for
Obesity and Obesity-related Medical Conditions
Pfizer 381
Post-approval studies (Phase 4)Study completedNCT01051674
What this trial is testing

A Very High Fiber Diet Versus a Low-carbohydrate Diet for Weight Loss

Who this might be right for
ObesityType 2 Diabetes
Loma Linda University 173
Large-scale testing (Phase 3)Looking for participantsNCT07784725
What this trial is testing

Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus

Who this might be right for
Obesity or Overweight
AstraZeneca 2,500
Testing effectiveness (Phase 2)Looking for participantsNCT06717698
What this trial is testing

A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease

Who this might be right for
Chronic Kidney Disease
Novo Nordisk A/S 465
Early research (Phase 1)Study completedNCT06567041
What this trial is testing

A Research Study of How Safe a New Medicine Called NNC0519 0130 is and to Test Its Effect in People Living With Excess Body Weight With or Without Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2Obesity
Novo Nordisk A/S 82
Testing effectiveness (Phase 2)Active Not RecruitingNCT07400588
What this trial is testing

Aleniglipron Phase 2 in Type 2 Diabetes Mellitus

Who this might be right for
ObeseObesityObesity Type 2 Diabetes Mellitus+1 more
Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics 58
Not applicableStudy completedNCT04127994
What this trial is testing

Glycemic Variability Comparing Two vs Five Meals in Type 2 Diabetes

Who this might be right for
Diabetes Mellitus Type 2Overweight and ObesityMeal Time
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran 50
Testing effectiveness (Phase 2)Study completedNCT05669599
What this trial is testing

Dose-ranging Study to Evaluate the Efficacy, Safety, and Tolerability of AMG 133 in Adult Subjects With Overweight or Obesity, With or Without Type 2 Diabetes Mellitus

Who this might be right for
ObesityOverweightType 2 Diabetes Mellitus
Amgen 592
Testing effectiveness (Phase 2)Study completedNCT06737042
What this trial is testing

Efficacy and Safety of GZR18 Every 2 Weeks Versus Tirzepatide and Placebo in Obese or Overweight Participants

Who this might be right for
Obesity and Overweight
Gan and Lee Pharmaceuticals, USA 326
Testing effectiveness (Phase 2)Study completedNCT05936151
What this trial is testing

Retatrutide (LY3437943) on Renal Function in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes

Who this might be right for
Overweight or ObesityCKDType 2 Diabetes
Eli Lilly and Company 146
Large-scale testing (Phase 3)Active Not RecruitingNCT06918405
What this trial is testing

Efficacy and Safety of Tirzepatide for Weight Management

Who this might be right for
Obesity and Obesity-related Medical Conditions
Chittagong Medical College 440
Not applicableStudy completedNCT01559896
What this trial is testing

Egg Protein Hydrolysate and Vascular Function

Who this might be right for
Arterial StiffnessDietary ModificationImpaired Glucose Tolerance+1 more
Maastricht University Medical Center 40
Large-scale testing (Phase 3)Study completedNCT05024032
What this trial is testing

Tirzepatide (LY3298176) in Chinese Participants Without Type 2 Diabetes Who Have Obesity or Overweight (SURMOUNT-CN)

Who this might be right for
ObesityOverweightMetabolism and Nutrition Disorder
Eli Lilly and Company 210
Not applicableUnknownNCT06146036
What this trial is testing

Effects of Different ''Exercise Snacking'' Modalities on Glycemic Control in Patients With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2Overweight or Obesity
University of Nis 20
Early research (Phase 1)Study completedNCT00551564
What this trial is testing

Study to Determine the Utility of Novel Technologies and Biomarkers to Measure Human Response to Rosiglitazone Maleate

Who this might be right for
Diabetes Mellitus, Type 2
GlaxoSmithKline 36
Not applicableStudy completedNCT01186952
What this trial is testing

Exercise Program Combined or Not With Nutritional intErvention in Adults With tyPe 2 Diabetes

Who this might be right for
OverweightObesityType 2 Diabetes
Institut de Recherches Cliniques de Montreal 90
Large-scale testing (Phase 3)Looking for participantsNCT07282600
What this trial is testing

Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

Who this might be right for
OverweightObesity
Eli Lilly and Company 1,035
Next Page